lamotrigine has been researched along with ketamine in 27 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (3.70) | 18.2507 |
2000's | 10 (37.04) | 29.6817 |
2010's | 11 (40.74) | 24.3611 |
2020's | 5 (18.52) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Del Bianco, PL; Nicolodi, M; Sicuteri, F | 1 |
Anand, A; Berman, RM; Cappiello, A; Charney, DS; Hu, XS; Krystal, JH; Oren, DA | 1 |
Shim, SS | 1 |
Anand, A; Krystal, JH; Moghaddam, B | 1 |
Kalkman, HO | 1 |
Brody, SA; Geyer, MA; Large, CH | 1 |
Howland, RH | 1 |
Cilia, J; Hatcher, P; Jones, DN; Reavill, C | 1 |
Deakin, JF; Dursun, SM; Hallak, JE; Lees, J; McKie, S; Williams, SR | 1 |
Garcia, R; Hunt, MJ; Kasicki, S; Large, CH | 1 |
aan het Rot, M; Charney, DS; Collins, KA; Mathew, SJ; Murrough, JW; Reich, DL | 1 |
Cha, DS; Kim, RD; Mansur, RB; McIntyre, RS | 1 |
Brammer, M; Doyle, OM; Joules, R; Mehta, MA; O'Daly, OG; Schwarz, AJ; Williams, SC | 1 |
de Simoni, S; Doyle, O; Mehta, MA; Schwarz, AJ; Shcherbinin, S; Zelaya, FO | 1 |
Chen, CK; Chen, LY; Huang, MC; Lin, SK | 1 |
Andrade, C | 1 |
Afridi, S; Viana, M | 1 |
Chan, MH; Chen, HH; Hsiao, YC; Lee, MY | 1 |
Anand, A; Bakal, O; Esa, WAS; Fang, J; Maheshwari, K; Sessler, DI; Turan, A; Xuan, P | 1 |
Cubała, WJ; Jakuszkowiak-Wojten, K; Wiglusz, MS; Wilkowska, A | 1 |
Abram, SV; Bustillo, JR; Calhoun, VD; Ford, JM; Fryer, SL; Krystal, JH; Lim, KO; Loewy, RL; Mathalon, DH; Preda, A; Roach, BJ; Stuart, BK; van Erp, TGM | 1 |
Beckmann, C; Carstens, L; Gärtner, M; Grimm, S; Hertrampf, R; Keicher, C; Meiering, MS; Mennes, M; Weigand, A; Weigner, D; Wunder, A | 2 |
7 review(s) available for lamotrigine and ketamine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Antischizophrenic activity independent of dopamine D2 blockade.
Topics: Amino Acid Transport System X-AG; Animals; Antipsychotic Agents; Brain Chemistry; Dopamine D2 Receptor Antagonists; Drug Design; Drug Evaluation, Preclinical; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Female; Frontal Lobe; Glutamate Plasma Membrane Transport Proteins; Glutamic Acid; Humans; Interneurons; Ketamine; Lamotrigine; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Receptor, Metabotropic Glutamate 5; Receptors, AMPA; Receptors, GABA; Receptors, Glutamate; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Schizophrenia; Symporters; Triazines | 2002 |
Glutamate-modulating drugs & the treatment of mental disorders.
Topics: Acamprosate; Amantadine; Cycloserine; Glutamic Acid; Humans; Ketamine; Lamotrigine; Memantine; Mental Disorders; Psychotropic Drugs; Riluzole; Taurine; Triazines | 2007 |
A review of FDA-approved treatment options in bipolar depression.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzhydryl Compounds; Benzodiazepines; Bipolar Disorder; Central Nervous System Stimulants; Depressive Disorder; Dibenzothiazepines; Drug Approval; Drug Combinations; Excitatory Amino Acid Antagonists; Fluoxetine; Humans; Isoindoles; Ketamine; Lamotrigine; Lurasidone Hydrochloride; Modafinil; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Thiazoles; Triazines; United States; United States Food and Drug Administration | 2013 |
Ketamine for Depression, 5: Potential Pharmacokinetic and Pharmacodynamic Drug Interactions.
Topics: Antidepressive Agents; Benzodiazepines; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP3A; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Humans; Ketamine; Lamotrigine; Polymorphism, Genetic; Risk Factors; Triazines | 2017 |
Migraine with prolonged aura: phenotype and treatment.
Topics: Humans; Ketamine; Lamotrigine; Migraine with Aura; Phenotype; Pilot Projects; Randomized Controlled Trials as Topic; Treatment Outcome; Triazines; Tryptamines | 2018 |
Ketamine and Lamotrigine Combination in Psychopharmacology: Systematic Review.
Topics: Animals; Antidepressive Agents; Depression; Humans; Ketamine; Lamotrigine; Psychopharmacology | 2022 |
8 trial(s) available for lamotrigine and ketamine
Article | Year |
---|---|
Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists.
Topics: Adult; Affect; Brief Psychiatric Rating Scale; Cognition Disorders; Double-Blind Method; Excitatory Amino Acid Antagonists; Female; Glutamates; Humans; Ketamine; Lamotrigine; Male; Mental Disorders; Perceptual Disorders; Placebos; Psychiatric Status Rating Scales; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Schizophrenic Psychology; Triazines; Verbal Learning | 2000 |
Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study.
Topics: Adult; Anticonvulsants; Awareness; Brain; Brief Psychiatric Rating Scale; Cross-Over Studies; Dissociative Disorders; Double-Blind Method; Excitatory Amino Acid Antagonists; Frontal Lobe; Glutamic Acid; Gyrus Cinguli; Humans; Image Enhancement; Image Processing, Computer-Assisted; Infusions, Intravenous; Ketamine; Lamotrigine; Magnetic Resonance Imaging; Male; Oxygen; Premedication; Psychoses, Substance-Induced; Receptors, N-Methyl-D-Aspartate; Statistics as Topic; Triazines | 2008 |
Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial.
Topics: Adult; Aged; Depression; Drug Interactions; Drug Resistance; Excitatory Amino Acid Antagonists; Female; Hallucinogens; Humans; Injections, Intravenous; Ketamine; Lamotrigine; Male; Middle Aged; Pilot Projects; Placebos; Riluzole; Secondary Prevention; Time Factors; Treatment Outcome; Triazines | 2010 |
Modulatory effects of ketamine, risperidone and lamotrigine on resting brain perfusion in healthy human subjects.
Topics: Adult; Brain; Dopamine Antagonists; Double-Blind Method; Excitatory Amino Acid Antagonists; Glutamic Acid; Healthy Volunteers; Humans; Ketamine; Lamotrigine; Male; Receptors, N-Methyl-D-Aspartate; Risperidone; Triazines; Young Adult | 2015 |
Lamotrigine for reducing ketamine-induced psychologic disturbances: A pilot randomized and blinded trial.
Topics: Analgesics; Anticonvulsants; Humans; Ketamine; Lamotrigine; Pilot Projects; Research Design | 2021 |
Validation of ketamine as a pharmacological model of thalamic dysconnectivity across the illness course of schizophrenia.
Topics: Glutamates; Hallucinations; Humans; Ketamine; Lamotrigine; Magnetic Resonance Imaging; Receptors, N-Methyl-D-Aspartate; Schizophrenia | 2022 |
Modulatory Effects of Ketamine and Lamotrigine on Cognition: Emotion Interaction in the Brain.
Topics: Anticonvulsants; Brain; Cognition; Emotions; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Ketamine; Lamotrigine | 2023 |
Region- and time- specific effects of ketamine on cerebral blood flow: a randomized controlled trial.
Topics: Anticonvulsants; Brain; Cerebrovascular Circulation; Glutamates; Humans; Ketamine; Lamotrigine | 2023 |
12 other study(ies) available for lamotrigine and ketamine
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Modulation of excitatory amino acids pathway: a possible therapeutic approach to chronic daily headache associated with analgesic drugs abuse.
Topics: Acetates; Adult; Amines; Chronic Disease; Cyclohexanecarboxylic Acids; Excitatory Amino Acid Antagonists; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Ketamine; Lamotrigine; Male; Middle Aged; Migraine Disorders; Opioid-Related Disorders; Substance Withdrawal Syndrome; Triazines | 1997 |
Is NMDA receptor hypofunction in schizophrenia associated with a primary hyperglutamatergic state?
Topics: Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Ketamine; Lamotrigine; Models, Biological; Neurons; Pyramidal Cells; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Synaptic Transmission; Triazines | 2002 |
Effects of NMDA receptor antagonists: implications for the pathophysiology of schizophrenia.
Topics: Animals; Dopamine; Glutamates; Humans; Ketamine; Lamotrigine; Models, Animal; Phencyclidine; Prefrontal Cortex; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Synaptic Transmission; Triazines | 2002 |
Lamotrigine prevents ketamine but not amphetamine-induced deficits in prepulse inhibition in mice.
Topics: Acoustic Stimulation; Amphetamine; Animals; Anticonvulsants; Behavior, Animal; Central Nervous System Stimulants; Dose-Response Relationship, Radiation; Drug Interactions; Excitatory Amino Acid Antagonists; Ketamine; Lamotrigine; Male; Mice; Mice, Inbred Strains; Neural Inhibition; Reflex, Startle; Species Specificity; Triazines | 2003 |
(+/-) Ketamine-induced prepulse inhibition deficits of an acoustic startle response in rats are not reversed by antipsychotics.
Topics: Animals; Antipsychotic Agents; Clozapine; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Glutamic Acid; Haloperidol; Ketamine; Lamotrigine; Male; Pyridines; Rats; Rats, Sprague-Dawley; Reflex, Startle; Risperidone; Schizophrenia; Sulfonamides; Thiophenes; Triazines | 2007 |
Modulation of high-frequency oscillations associated with NMDA receptor hypofunction in the rodent nucleus accumbens by lamotrigine.
Topics: Algorithms; Analysis of Variance; Animals; Dose-Response Relationship, Drug; Electroencephalography; Excitatory Amino Acid Antagonists; High-Frequency Ventilation; Ketamine; Lamotrigine; Male; Membrane Potentials; Microinjections; Motor Activity; Nucleus Accumbens; Rats; Rats, Wistar; Spectrum Analysis; Time Factors; Triazines | 2008 |
Ketamine induces a robust whole-brain connectivity pattern that can be differentially modulated by drugs of different mechanism and clinical profile.
Topics: Adult; Brain; Brain Mapping; Cross-Over Studies; Dopamine Antagonists; Double-Blind Method; Excitatory Amino Acid Antagonists; Humans; Ketamine; Lamotrigine; Magnetic Resonance Imaging; Male; Receptors, N-Methyl-D-Aspartate; Risperidone; Triazines; Young Adult | 2015 |
Potential benefit of lamotrigine in managing ketamine use disorder.
Topics: Adult; Animals; Excitatory Amino Acid Antagonists; Humans; Ketamine; Lamotrigine; Male; Models, Biological; Phencyclidine Abuse; Triazines | 2016 |
Lamotrigine attenuates the motivation to self-administer ketamine and prevents cue- and prime-induced reinstatement of ketamine-seeking behavior in rats.
Topics: Analgesics; Animals; Anticonvulsants; Cues; Drug-Seeking Behavior; Extinction, Psychological; Ketamine; Lamotrigine; Locomotion; Male; Motivation; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Self Administration | 2019 |